Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial Respiration
Iga Walczak(Gdańsk Medical University), Barbara Kutryb-Zając(Gdańsk Medical University), Marcin Hellmann(Gdańsk Medical University), Filip Rolski(Postgraduate School of Molecular Medicine), Alicja Braczko(Gdańsk Medical University), Krzysztof Urbanowicz(Gdańsk Medical University), Ryszard T. Smoleński(Gdańsk Medical University), Maria Tarnawska(Gdańsk Medical University), Roksana Knapczyk(Gdańsk Medical University), Aleksandra Paterek(Postgraduate School of Molecular Medicine), Aleksandra Parzuchowska(Gdańsk Medical University), Michał Ma̧czewski(Postgraduate School of Molecular Medicine)
Cited by 6
Related Papers
Complexity of TNF-α Signaling in Heart Disease
|Journal of Clinical Medicine|2020|171
TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells
|Cardiovascular Research|2023|48
Angiotensin II receptor 1 controls profibrotic Wnt/β-catenin signalling in experimental autoimmune myocarditis
|Cardiovascular Research|2021|41
Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis
|Arthritis & Rheumatology|2021|28
Cardiac Fibrosis: Mechanistic Discoveries Linked to SGLT2 Inhibitors
|Pharmaceuticals|2025|21